[HYDROXY]CHLOROQUINE.

HCQ is a drug which is normally used to treat malaria. It has been shown to inhibit SARS-CoV-2 replication when tested in vitro and also appears to be effective in treating COVID-19 patients’ symptoms. According to Professor Didier Raoult in France, when 24 patients received this drug, they showed “a rapid and effective speeding up of their healing process...". Clinical trials for HCQ have been announced by the French Health Minister, FDA and NY state governor. While the FDA recommended against the use of HCQ with azithromycin, Phase III clinical trial of HCQ was approved on 20 April 2020…

FDA has pulled emergency use authorization of HCQ for COVID-19 on 15 June 2020.